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Abstract  22 
Introduction: Patellar mobility is often routinely assessed in people with 23 
patellofemoral pain (PFP) in clinical practice. This study assessed the stability of the 24 
data when measuring patellar mobility using the total medial-lateral patellar glide test 25 
across multiple repetitions. It also compared patellar mobility of people with healthy 26 
knees to people with PFP and within subgroups of PFP.  27 
Methods:  Twenty-two people without knee problems underwent five repetitions of 28 
the total medial-lateral patellar glide test. Differences in mean value for each 29 
repetition and the intra-class correlations (ICC) between the first assessment and the 30 
average values of additional repetitions were calculated. Mean patellar mobility was 31 
compared with 127 participants with PFP who took part in a previously published 32 
subgrouping study. Differences between the healthy knee group and PFP subgroups 33 
were also explored using a one-way ANOVA with pairwise comparisons.  34 
Results: The mean patellar mobility in healthy individuals was 16.4 mm (SD 5.3), 35 
difference in mean patellar mobility across repetitions was minimal and the ICC 36 
ranged between 0.93 and 0.95. People with PFP had significantly lower patellar 37 
mobility than the healthy knee group. Two of three PFP subgroups had statistically 38 
significantly lower mean patellar mobility (difference in mean -5.6mm and -6.5mm; 39 
P<0.001).  40 
Discussion: A single medial-lateral patellar glide test appears as informative as 41 
repeated tests in practice. One off measures of patellar mobility using the total 42 
medial-lateral patellar glide test may identify subgroups of PFP to help guide 43 
treatment in clinical practice. Further work is needed to assess other reliability 44 
parameters for this measure. 45 
Contributions of the Paper: 46 
• A one off measure of the total medial-lateral patellar mobility is as accurate as 47 
the average of multiple measures.  48 
• There is a difference between healthy participants and people with PFP in 49 
total patellar mobility 50 
• There is evidence of lower patella mobility as measured by a one off measure 51 
of the total medial lateral patellar mobility in some subgroups of PFP patients 52 
  53 
Introduction 54 
Patellofemoral pain (PFP) is a common disorder in younger adults.  Despite it being 55 
seen by many as a trivial condition [1], over 90% of those presenting with the 56 
condition are still suffering four years after diagnosis [2-4]. There is an indication that 57 
participants could develop osteoarthritis at a later stage [3], however the link 58 
between PFP and osteoarthritis in later life is currently weak due to the limited 59 
evidence base [5]. 60 
Assessment of patellar mobility is common in clinical practice for patients suspected 61 
of having PFP. This is as one of the dominant theories for the aetiology of PFP has 62 
been malalignment and/or mal-tracking of the patella through the trochlear groove. 63 
This mal-tracking leads to reduced patellofemoral joint contact area which increases 64 
the load on that joint and, hence, may contribute to increased pain [6]. Consequently, 65 
many treatments for patellofemoral pain have focused on improving patellofemoral 66 
control, through, for example, proximal (hip abductors and quadriceps) strengthening 67 
and stretching exercises [7], patella mobilisations [8], patella taping [9].  Both 68 
hypomobility and hypermobility of the patella are considered to be clinically 69 
important. However, there has been increasing recognition that the aetiology of PFP 70 
is more complex and that there may be other mechanisms contributing to reduced 71 
patellofemoral joint contact area and/or elevated patellofemoral joint loading (Powers 72 
et al 2017). This has led to increased interest in identifying subgroups of 73 
patellofemoral pain so that treatment can be targeted more optimally and efficiently 74 
[10]. 75 
In a recently published subgrouping study (TIPPS), we identified three subgroups 76 
among 127 adults aged 18 to 40 years with PFP using six clinical tests routinely 77 
available in practice [11]. These subgroups included a ‘weak and tight’ (39%) 78 
subgroup, a ‘weak and pronated feet’ (39%) subgroup and a ‘strong’ (22%) 79 
subgroup.  One of the clinical tests used in TIPPS was the total medial-lateral 80 
patellar glide test.  The mean patellar mobility using this test was similar in the ‘weak 81 
and tight’ subgroup and the ‘strong’ subgroup but it was significantly higher in the 82 
‘weak and pronated’ subgroup [11]. One difficulty in interpreting this data clinically 83 
was the limited published data on normative means, standard deviations or ranges. 84 
Studies that had been published had either been in adolescents only [12], had used 85 
different methods to measure patellar mobility [13], or used methods that could not 86 
be repeated in routine practice [14,15]. 87 
From the literature, it was also unclear how many measurements were needed for an 88 
accurate assessment. In the TIPPS study, only one measurement of patellar mobility 89 
using the lateral-medial patellar glide test was taken; this is in line with routine 90 
clinical practice.  This is because the method involves making a mark on the knee 91 
with a pen.  However, others have also repeated the patellar mobility measurement 92 
three times [13,14]. This is also usual practice for many of the other clinical tests 93 
used in the TIPPS study and in clinical practice, such as measuring quadriceps 94 
strength, which involves taking the average of three measurements to achieve stable 95 
values [11]. 96 
Therefore, in this study, we examined the stability of the data from the medial-lateral 97 
patellar glide test across sequential measurements. Additionally, we aimed to 98 
measure patellar mobility in a group of young adults without a recent history of knee 99 
pain, to provide data for comparison with that of patellofemoral pain patients [11].   100 
 101 
 102 
Methods 103 
This study was approved by the University of Central Lancashire ethics committee 104 
(Science Technology, Engineering, Medicine and Health (STEMH) project number 105 
355).  106 
 107 
Participants  108 
Twenty-three participants were recruited through advertising across the University 109 
and through word of mouth. Participants were aged between 18 and 40 years 110 
without current neurological or musculoskeletal disorders, knee pain or history of 111 
surgery to the lower extremities. Informed written consent was obtained. We were 112 
unable to fully test one participant in this study as they were hyper-sensitive to the 113 
patellae being touched, but a complete dataset was available for the remaining 22 114 
participants. 115 
The comparison data consisted of 127 patients with patellofemoral pain who were 116 
included in the TIPPS subgrouping study. These patients were aged between 18 and 117 
40 years and diagnosed with non-speciﬁc unilateral or bilateral PFP. Detailed 118 
information about these patients can be found in Selfe et al 2016.   119 
 120 
Procedure 121 
All participants were asked to attend one testing session at a University 122 
Physiotherapy clinic, where first the participant’s age, gender, height and weight 123 
were recorded. One researcher, a trained physiotherapist, performed the total 124 
medial-lateral patellar glide test. The participant lay in a supine position with the 125 
quadriceps relaxed and knees extended.  After a verbal explanation of the test, the 126 
researcher applied a medially directed force to the lateral border of the patella with 127 
the thumbs and the maximum displacement of the inferior pole of the patella was 128 
marked on the skin with a piece of tape. This was followed by a laterally directed 129 
force to the medial border of the patella and again the maximum displacement of the 130 
inferior pole of the patella was marked on the skin using tape. The distance between 131 
medial displacement tape and the lateral displacement tape was measured by the 132 
researcher with a tape measure in millimeters and was recorded as the total 133 
displacement of the inferior pole of the patella in the coronal plane (Figure 1). Both 134 
pieces of tape were removed between tests. This was repeated five times, with a 135 
one-minute rest between each test. Then the contralateral leg was measured in the 136 
same manner. Usually in clinical practice, markings are made on the skin with a pen 137 
but tape was used in this study so that researcher had no visual clues from previous 138 
tests.   139 
(Insert Figure 1 here) 140 
 141 
Statistical Analysis 142 
Individuals with healthy knees: the mean (and standard deviation) patellar mobility 143 
was calculated for the first assessment of the 44 legs of the 22 participants with 144 
healthy knees. The difference in mean (95% confidence intervals (CI)) between left 145 
and right legs and between dominant and non-dominant legs was calculated.  For 146 
each of the other four repetitions, the mean value for that repetition and the average 147 
value of the means of the repetition and each preceding repetition were calculated. 148 
The intra-class correlations (ICC) between the first assessment and the average 149 
values were also calculated using SPSS statistical package version 23 (SPSS Inc, 150 
Chicago, IL) using average measures, absolute-agreement, 2-way mixed-effects 175 
model [16]. An ICC over 0.75 was indicative of an excellent correlation [17].  176 
 177 
Comparison with mean patellar mobility in PFP patients:  178 
Mean patellar mobility for the first assessment of the 22 participants with healthy 179 
knees were compared with the mean patellar mobility observed in the TIPPS study 180 
population overall and, then, with each of the three PFP subgroups identified in the 181 
TIPPS study [11]. In this latter study the test was only applied on one occasion using 182 
the same technique as described above with the exception that only the leg with PFP 183 
(or if bilateral, worst pain) was measured and skin marks were made with a pen.   184 
As both legs on an individual with healthy knees were measured, there was potential 185 
for introducing a clustering effect, which would inflate the standard error of statistical 186 
tests, when comparing the mean values with those of the TIPPS study. Therefore, 187 
the data was explored for potential clustering at participant level (two legs) by 188 
estimating the variance inflation factor.  As the variance inflation factor was 1.29, 189 
suggesting clustering between legs, the patellar mobility value from one leg was 190 
randomly selected from each participant, using an online randomization program 191 
(https://www.randomizer.org). This leg was used in comparisons between the healthy 192 
knee group and the PFP group, using an unpaired t-test, and the 3 PFP subgroups, 193 
using one way ANOVA and pairwise comparisons with Bonferroni correction in the 194 
presence of a statistically significant difference. 195 
Sample size 196 
Assuming that the mean patellar mobility in adults without PFP (healthy knees) was 197 
similar to that of adults with PFP, i.e., a mean of 12.2 mm and SD of 4.6  (Selfe et al 198 
2016), we estimated we would need at least 40 knees (20 participants) to estimate to 199 
+/- 1.5 mm with 95% confidence. A sample of 20 healthy knee participants would 200 
allow a difference of at least 4.6 mm (the smallest difference between two TIPPS 201 
subgroups) to be detected between the healthy knee and PFP group taking into 202 
account the imbalance between the number of observations in the healthy knee and 203 
the TIPPS subgroups (smallest 1 to 1.45) for a 99% statistical significance (to allow 204 
for the Bonferroni Correction for 4 groups) and a study power of 80%.  205 
 206 
Results 207 
Of the 22 participants, 13 (60%) were female. The mean age was 26 years (SD 6.7), 208 
the mean weight was 71.2 kg (SD 13.9) and mean height 1.7 m (SD 0.09). This was 209 
similar to the TIPPS subgrouping study in which 66% were female, the mean age 210 
was 26 years (SD 5.6), the mean weight 73.5 kg (SD 18.3) and height 1.7 m (SD 211 
0.11) (Selfe et al 2016). 212 
 213 
Total medial-lateral patellar mobility in 44 healthy knees: The mean patellar mobility 214 
for the 44 healthy knees on first measurement was 15.9 (SD 5.0) mm. There was no 215 
statistically significant difference in mean patellar mobility between the right and left 216 
leg (difference in mean = 0.6 (SD 3.8) mm, 95% CI for difference in mean -1.1 to 2.3 217 
mm; t-test 0.729; df 21 ;P=0.47), and dominant and non-dominant side (difference in 218 
mean = 0.1 (SD 3.8) mm, 95% CI for difference in mean -1.6 to 1.8; t-test 0.166; df 219 
21; P=0.87). The mean patellar mobility and the ICC appeared to be very stable over 220 
the multiple repetitions (Table 1). 221 
Insert Table 1 here 222 
 223 
A comparison of healthy individuals with people with PFP: Following random 224 
selection of one knee from each participant with healthy knees, 14 right and 8 left 225 
healthy knees were available for comparison with the 127 knees from the PFP 226 
participants in the TIPPS study.  The mean patellar mobility in the 22 randomly 227 
selected healthy knees was 16.4 mm (SD 5.3) and in those with PFP was 12.2 mm 228 
(SD 4.6) (table 2). This difference was statistically significant (difference in mean 4.2 229 
(SD 4.9) mm, 95% CI for difference in mean -6.3 to -2.0 mm; t= -3.81, df 1, 230 
P<0.001). When the data of the healthy knee group was compared to the three PFP 231 
subgroups, a significant difference was observed (F= 22.48, P<0.001), but pairwise 232 
comparisons showed that only the ‘weak and tighter’ (P<0.001) and ‘strong’ 233 
subgroups (P<0.001) had significantly lower mean patella mobility (Table 2). There 234 
were no significant difference in mean patellar mobility between the ‘weak and 235 
pronated feet’ PFP subgroup and the healthy knees group (P=1.000) (Table 2).  236 
 237 
Insert Table 2 and Figure 2 here 238 
 239 
Discussion 240 
We have, for the first time, provided normative data for the medial-lateral patellar 241 
glide test as measured in adults. Our findings are similar to those reported for 242 
adolescents (mean 16.0 mm) using a similar technique [12].  However, our mean 243 
patellar mobility is considerably lower than what Witvrouw et al reported in a much 244 
larger sample of similar age [13]. In this study, though, medial and lateral mobility 245 
were performed separately and later added to calculate the total patellar mobility. 246 
This different execution might explain the difference between the values in the two 247 
studies.  248 
 249 
Like Witvrouw, however, we did find a difference in mean scores between those with 250 
healthy knees and those with PFP overall [13]. When different PFP subgroups were 251 
considered participants allocated to the ‘weak and tighter’ and ‘strong’ subgroups 252 
were found to have significantly lower patellar mobility than healthy participants, 253 
which provides some evidence for patellar hypomobility in these subgroups. Those 254 
participants who fell into the ‘weak and pronated feet’ subgroup had a similar mean 255 
patellar mobility to the healthy knee group.  This subgroup made up 39% of the PFP 256 
participants in the TIPPS study, but were this prevalence higher in other PFP 257 
samples, it might explain why some studies have not found a difference between 258 
PFP and healthy knee groups [14]. More research needs to be conducted to 259 
understand patella mobility in the weak and pronated PFP subgroup as a possible 260 
explanation for the lack of difference could be the participants’ position during the 261 
test. In standing, pronation of the feet will lead to an internal rotation of the tibia, 262 
which causes the patella to move medially [18]. This is turn can increase the contact 263 
area between the medial patella facet and the femoral condyle [18] and potentially 264 
reduce patellar mobility.  However, in this test the participants were in a supine 265 
position and therefore internal rotation of the tibia and with it reduction of patellar 266 
mobility might not have occurred.  267 
 268 
This study also suggests that a single measurement of the medial-lateral glide test 269 
as practiced routinely is sufficient. This has implications for clinical practice, as only 270 
one assessment will reduce the time required to be spent on clinical assessment. 271 
The difference in mean patellar mobility across repetitions was minimal and the ICC 272 
remained above 0.9, well into the excellent range [17].  273 
 274 
This study was not designed to measure the standard error of measurement (SEM), 275 
as there was not enough time between recordings on participants to reduce the risk 276 
of recall bias. This limits the interpretation of the differences between the PFP 277 
subgroups and those with healthy knees.  However, if we were to assume no recall 278 
bias, then the SEM for healthy knees is 1.24mm (when SD*√(1-ICC) using the 1st 279 
and 2nd repetitions: see table 1) [19] and the minimal detectable change (MDC95) 280 
3.4mm (when MDC95=1.96*SEM*√2) [20]. As the MDC is less than the difference 281 
between the healthy knees and the weak and tight PFP subgroup and the difference 282 
between the healthy knees and the strong PFP subgroup, if would suggest that 283 
these differences are real.  Further research is needed to estimate the SEM under 284 
more optimal conditions in PFP patients to facilitate comparisons between 285 
subgroups, and to estimate other important measurement properties, such as, inter-286 
rater reliability. 287 
 288 
It might be argued that another important limitation of this study was the non-289 
randomization of the ordering of the test between left and right leg, but the mean 290 
patellar mobility was similar in the two legs. Data was lost because our approach to 291 
handling clustering was to randomly select one leg per healthy knee participant for 292 
comparison with the PFP group/subgroups. However, this was necessary to ensure 293 
consistency across groups as only one leg was measured in the TIPPS study, even 294 
when both knees were affected.   295 
 296 
Conclusion 297 
The total medial-lateral patellar mobility can be measured reliably in a one-off 298 
measurement using the patellar glide test. The mean patellar mobility of healthy 299 
adult participants was significantly different to the mean patellar mobility in 300 
participants with PFP and suggests hypomobility in at least two subgroups of people 301 
with PFP. This could help direct therapeutic intervention in these patients but further 302 
work is needed on the diagnostic properties of this test.   303 
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Table 1: Stability of the data from the total medial-lateral patellar glide test in healthy 400 
knees (n=44) 401 
Abbreviations: mm= millimeters, SD=standard deviation, ICC= intra-class correlation 402 
coefficient, CI= 95% confidence interval n/a = not applicable,* 1st compared to 403 
average of repetitions  404 
 Repetition 
1 2 3 4 5 
Mean in mm 
 
15.9  
(SD 5.0) 
15.9  
(SD 4.4) 
15.8  
(SD 4.2) 
15.8  
(SD 4.5) 
15.8  
(SD 4.4) 
Average of mean 
over repetitions in 
mm 
n/a 15.91  
(SD 4.69) 
 
15.89  
(SD 4.51) 
 
15.87  
(SD 4.50) 
 
15.85  
(SD 4.46) 
 
ICC (CI)*  n/a 0.93 
(0.86-0.96) 
0.95 
(0.90-0.97) 
0.95 
(0.90-0.97) 
0.94 
(0.88-0.97) 
Table 2: Comparison of mean patellar mobility between healthy and PFP knees  
 
 
 
 
 
 
 
 
 
Abbreviations: N=number of participants in the group, mm= millimeters, SD=standard deviation, + one leg was randomly chosen, 
CI= confidence interval. 
  
 
Mean (SD) patellar 
mobility in mm and 
95% CI 
Difference  in mean (mm) between 
healthy knees group and PFP subgroup 
(95% CI difference in mean) 
Pairwise 
comparison 
(p value) 
Healthy Knees 
(N=22)+ 
16.4 (5.3) 
14.0 – 18.7 
 --------- 
PFP subgroup-
weak and tighter 
(N=49) 
9.9 (3.6) 
8.9 - 10.9 
-6.5* 
(-9.3 to -3.7) 
<0.001 
PFP subgroup - 
weak and 
pronated (N=49) 
15.4 (4.6) 
14.1 - 16.7 
-1.0 
(-3.8 to 1.9) 
1.000 
PFP subgroup – 
strong (N=29) 
10.8 (3.0) 
9.6 - 11.9 
-5.6 
(-8.7 to -2.5) 
<0.001 
Figures 
 
Figure 1: the total medial-lateral patellar glide test with markings on the skin 
 
 
 
 
 
 
  
  
Figure 2: Box and Whisker plot for healthy participants and participants allocated to 
the three PFP subgroups.  
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